Evidence map›Paper›PMID 42011477›Full record

ArticleDose-response : a publication of International Hormesis Society

Integrating Adaptive Responses Into Hormesis: δ Plot Analysis of the Yonezawa Effect in the Micronucleus Test.

Shizuyo Sutou, Akiko Koeda, Kana Komatsu, Toshiyuki Shiragiku, Hiroshi Seki, Toshiyuki Kudo

Abstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shizuyo SutouSchool of Pharmacy, Shujitsu University, Okayama-shi, Okayama-ken, Japan.ORCID https://orcid.org/0000-0002-3660-1209
Akiko KoedaDrug Safety Laboratories, Shin Nippon Biomedical Laboratories, Ltd.
Kana KomatsuSafety Assessment Unit, SNBL INA Ltd.
Toshiyuki ShiragikuTokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., Tokushima-shi, Tokushima-ken, Japan.
Hiroshi SekiSafety Studies Section, BML Inc., Kawagoe-shi, Saitama-ken, Japan.
Toshiyuki KudoSchool of Pharmacy, Shujitsu University, Okayama-shi, Okayama-ken, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: Cells and organisms respond dynamically to environmental stimuli such as radiation and chemicals. Depending on the assay system, these responses have been described as hormesis, adaptive responses, J-shaped responses, and biphasic responses. In micronucleus assays using cultured cells, however, the intrinsically low baseline frequency of micronuclei makes it difficult to obtain a clear J-shaped dose-response curve characteristic of hormesis. To address this limitation, we conducted challenge and cross-challenge experiments. Methods: In challenge tests, cells were first exposed to low priming doses and then to a high challenging dose. In cross-challenge tests, cells were pretreated with low doses of one chemical (e.g., mitomycin C) and subsequently exposed to a high dose of another (e.g., AF-2). Results: In both approaches, pre-exposure suppressed micronucleus formation induced by the high dose. δ-Plot analysis was applied to quantify the Yonezawa effect, a well-established radiation-induced adaptive response. The data fit the δ-plot model well, indicating that the observed effects are consistent with hormesis as preconditioning. Conclusion: Because "adaptive response" is overly broad and terms such as "J-shaped response" or "biphasic response" are overly narrow, we propose integrating these phenomena under the concept of hormesis, providing a unified framework for interpreting low-dose biological effects.

Indexed as

challenging dosecross-adaptive responsehormeticpreconditioningpriming dose

Identifiers

PMID42011477
PMCPMC13091962

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.